PAIN SYNDROMES DEVELOPING IN PATIENTS DURING LONG-TERM HEMODIALYSIS


Cite item

Full Text

Abstract

Objective. To assess the frequency and intensity of painful muscle spasms (cramps) in patients with end-stage CKD during hemodialysis; to determine the impact of potentially modifiable risk factors on their development. Materials and Methods. The study involved 111 male and female patients receiving treatment on hemodialysis program. Crumps intensity was assessed using a brief pain questionnaire two hours after hemodialysis initiation, during three consecutive procedures. The HADS questionnaire was used to detect anxiety and depression. Blood pressure, interdialysis weight gain were evaluated during three consecutive dialysis procedures. Phosphate binders were taken into account for all patients in the sample. Serum concentrations of phosphorus (P), total calcium (Ca) and parathyroid hormone (iPTG) were determined in all patients. Results. The mean age of patients was 51.8 ± 2.3 years, the mean duration of hemodialysis treatment was 7.7 ± 0.9 years, the mean procedure duration was 12 ± 0.24 hours per week, the mean level of KT/V was 1.4 ± 0.03. The frequency of crumps was 55%, the mean intensity was 5.2±1.8 points by the numerical rating scale (NRS). Compared with the group of patients without crumps, the risk of pain muscle spasms increased with increasing age of patients, hemodialysis experience, interdialysis weight gain. An important modifiable risk factor was intradialysis hypotension (or 10.9 (95%CI 3,0; 38.9) p = 0.0002). Statistically significant differences between the groups with or without cramps not obtained on any of the three indicators of mineral metabolism (PTH (p = 0,87); P (p = 0,25); overall Ca (p = 0,70)). Conclusion. Painful muscle spasms (cramps) occur in every second patient on hemodialysis program. The impact on potentially modifiable risk factors for muscle spasms, such as interdialysis weight gain, hypotension during hemodialysis, and phosphorus level correction, can reduce the frequency and intensity of this type of pain syndrome.

About the authors

Arina P. Spasova

Medical Institution of Petrozavodsk State University

Email: arina22@mail.ru
MD, PhD, Assistant Professor of Chair of X-Ray diagnostic and X-Ray treatment with course of Critical and Respiratory Medicine of Medical Institution of Petrozavodsk State University, Petrozavodsk, 185910, Russian Federation Petrozavodsk, 185910, Russian Federation

O. Yu Barysheva

Medical Institution of Petrozavodsk State University

Petrozavodsk, 185910, Russian Federation

G. P Tikhova

Medical Institution of Petrozavodsk State University

Petrozavodsk, 185910, Russian Federation

References

  1. Pham P.C., Dewar K., Hashmi S., Toscano E., Pham P.M., Pham P.A., Pham P.T. Pain prevalence in patients with chronic kidney disease. Clin. Nephrol. 2010; 73 (4): 294-9.
  2. Finkelstein F.O., West W., Gobin J., Finkelstein S.H., Wuerth D. Spirituality, quality of life and the dialysis patient. Nephrol. Dial. Transplant. 2007; 22 (9): 2432-4.
  3. Rocco M.V., Burkart J.M. Prevalence of missed treatments and early sign-offs in hemodialysis patients. Journal of the American Society of Nephrology. 1993; 4 (5): 1178-83.
  4. Fidan F., B., Alkan B. M., Tousun A., Altunoglu A., and Ardicoglu. O. Quality of life and correlation with musculoskeletal problems, hand disability and depression in patients with hemodialysis. International Journal of Rheumatic Diseases. 2013.
  5. McGee S. R. Muscle cramps. Archives of Internal Medicine. 1990; 150 (3): 511-8.
  6. Canzanello V.J., Burkart J.M. Hemodialysis-associated muscle cramps. Semin Dial. 1992; 5: 299.
  7. Kobrin S.M., Berns J.S. Quinine--a tonic too bitter for hemodialysis-associated muscle cramps? Semin. Dial. 2007; 20: 396.
  8. Khajehdehi P., Mojerlou M., Behzadi S., and Rais-Jalali G. A. A randomized, double-blind, placebo-controlled trial of supplementaryvitamins E, C and their combination for treatment of haemodialysis cramps. Nephrology Dialysis Transplantation. 200; 16 (7): 1448-51.
  9. Lynch K. E., Feldman H. I., Berlin J. A., Flory J., Rowan C. G., Brunelli S. M. Effects of L-carnitine on dialysis-related hypotension and muscle cramps: a meta-analysis. American Journal of Kidney Diseases. 2008; 52 (5): 962-71.
  10. Kelber J., Slatopolsky E., and Delmez J. A. Acute effects of different concentrations of dialysate magnesium during high efficiency dialysis. American Journal of Kidney Diseases. 1994; 24 (3): 453-60.
  11. Ahsan M., Gupta M., Omar I. et al. Prevention of hemodialysis-related muscle cramps by intradialytic use of sequential compression devices: a report of four cases. Hemodialysis International. 2004; 8 (3): 283-6.
  12. Levin N.W., Kupin W.L., Zasuwa G., Venkat K., eds. Complications during hemodialysis. in Clinical Dialysis. 2nd Ed. Appleton and Lange, 1990; 172-201.
  13. Benna P., Lacquaniti F., Triolo G. Ferrero P. Bergamasco 13: Acute neurologic complications of hemodialysis. J. Neural Sej. 1981 2: 53-7.
  14. Lynch P. G., Abate M., Suh H., Wadhwa N. K. Magnesium and Muscle Cramps in End Stage Renal Disease Patients on Chronic Hemodialysis. Hindawi Publishing Corporation Advances in Nephrology. Volume 2014, Article ID 681969, 6 pages http://dx.doi.org/10.1155/2014/681969.
  15. Caplin B., Alston H., Davenport A. Does online haemodiafiltration reduce intra-dialytic patient symptoms? Nephron - Clinical Practice. 2014; 124 (3-4): 184-90.
  16. Bilbey D.L.J. and Prabhakaran V.M. Muscle cramps andmagnesium deficiency: case reports. Canadian Family Physician. 1996; 42 :1348-51.
  17. Weisbord S.D., Fried L.F., Arnold R.M. et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J. Am. Soc. Nephrol. 2005; 16: 2487-94.
  18. Davison S.N., Jhangri G.S. The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients. J. Pain Symptom Manage. 2005; 30: 465-73.
  19. Bi SH, Linke L., Wu J., Cheng L.T., Wang T., Ahmad S. Effects of beta-blocker use on volume status in hemodialysis patients. Blood Purif. 2012; 33 (4): 311-6.
  20. Parker K.P. Anxiety and complications in patients on hemodialysis. Nurs. Res. 1981; 30: 334-6.
  21. Cukor D., Coplan J., Brown C., Friedman S., Newville H., Safier M., Spielman L.A., Peterson R.A., Kimmel P.L. Anxiety disorders in adults treated by hemodialysis: a single-center study. Am. J. Kidney Dis. 2008; 52 (1): 128-36.
  22. Quellhorst E.A., Eduard A. Ultrafiltration and haemofiltration, practical applications. In: Drukker W., Parsons F.M., Maher J.F., eds. Replacement of Renal Function by Dialysis. 2nd Ed. Dordrecht, Kluwer. 1983: 265-74.
  23. Young E.W., Albert J.M., Satayathum S. et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2005; 67: 1179-87.
  24. Noordzij M., Boeschoten E.W., Bos W.J., Dekker F.W., Bossuyt P.M., Krediet R.T., Korevaar J.C. Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients. Nephrol. Dial. Transplant. 2007; 22 (10): 2944-9.
  25. Goldstein D.A., Chui L.A., Massry S.G. Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity. J. Clin. Invest. 1978; 62: 88-93.

Copyright (c) 2018 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies